• -
8 Results
Download CSV
A stethoscope on American paper currency.
U.S. Health System Transformation | Center for Health and Biosciences | Journal
Development of Machine Learning Algorithms for the Prediction of Financial Toxicity in Localized Breast Cancer Following Surgical Treatment
The authors sought to develop and test a tool that accurately predicts the unique financial burden to individual patients undergoing treatment for breast cancer. JCO Clinical Cancer Informatics, an American Society of Clinical Oncology Journal
Anaeze C. Offodile II, Chris Sidey-Gibbons, André Pfob, Malke Assad, Stefanos Boukovalas, Yu-Li Lin, Jesse Creed Selber, Charles Butler March 26, 2021
A needle poking a human cell.
Center for Health and Biosciences | Biomedical Research | Journal
Rethinking Human Embryo Research Policies
It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. Robust stakeholder engagement preceded adoption of the fourteen‐day limit and should arguably be part of efforts to reassess it, write the authors.
Kirstin R.W. Matthews, Ana S. Iltis, Daniel S. Wagner, Nuria Gallego Marquez, Jason Scott Robert, Inmaculada de Melo-Martín, Marieke Bigg, Sarah Franklin, Soren Holm, Ingrid Metzler, Matteo A. Molè, Jochen Taupitz, Giuseppe Testa, Jeremy Sugarman February 26, 2021
A child stands on parent's feet.
Child Health Policy | Center for Health and Biosciences | Journal
Relationships Between Adverse Childhood Experiences and Protective Factors Among Parents At-Risk for Child Maltreatment
In this study, the authors found that a parental history of ACEs can weaken protective factors — such as resilience and social connections — that could mitigate the risk of perpetuating the trauma in the next generation.  Children and Youth Services Review: http://bit.ly/2UmOH95
Lisa Panisch, Catherine LaBrenz, Jennifer Lawson, Beth Gerlach, Patrick S. Tennant, Swetha Nulu, Monica Faulkner February 3, 2020
A nurse and a patient smile at each other.
Center for Health and Biosciences | Biomedical Research | Journal
Regulating the Therapeutic Translation of Regenerative Medicine
Regenerative medicine and stem cell research are exciting new fields. But as the fields progress toward clinical therapies, controversies emerge. Hype surrounding stem cell research has caused an increase in their use in interventions that are not clinically proven. Furthermore, the regulatory agencies have a lot of difficulty dealing with cell therapies, which are distinctly different from drugs and medical devices they more commonly approve. To move the field forward, advocates, regulators and scientists need to come together to find new options for stem cell research oversight that protects both the patients and the research field.
Maude Rowland Cuchiara, Jackie Olive, Kirstin R.W. Matthews July 6, 2015